Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Classification of Leukocytes01:30

Classification of Leukocytes

2.0K
Leukocytes are classified into two groups based on the presence or absence of cytoplasmic granules. Granular leukocytes, which contain granules, belong to the myeloid lineage and are divided into three subtypes: neutrophils, eosinophils, and basophils. These cells are roughly spherical and characterized by the granules in their cytoplasm.
Neutrophils are the most abundant type of granular leukocytes, comprising 50-70% of all leukocytes. They feature small, evenly distributed granules and a...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Benign and Malignant Breast Tumor Classification in Ultrasound and Mammography Images via Fusion of Deep Learning and Handcraft Features.

Entropy (Basel, Switzerland)·2023
Same author

Despeckling of Ultrasound Images Using Block Matching and SVD in Sparse Representation.

Sensors (Basel, Switzerland)·2022
Same author

Melanoma and Nevus Skin Lesion Classification Using Handcraft and Deep Learning Feature Fusion via Mutual Information Measures.

Entropy (Basel, Switzerland)·2020
See all related articles

Related Experiment Video

Updated: Jul 23, 2025

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.5K

Explainable CAD System for Classification of Acute Lymphoblastic Leukemia Based on a Robust White Blood Cell

Jose Luis Diaz Resendiz1, Volodymyr Ponomaryov1, Rogelio Reyes Reyes1

  • 1Instituto Politecnico Nacional, Escuela Superior de Ingenieria Mecanica y Electrica-Culhuacan, Av. Sta. Ana 1000, Mexico City 04440, Mexico.

Cancers
|July 14, 2023
PubMed
Summary

This study introduces an Explainable AI (XAI) system for leukemia diagnosis, enhancing computer-aided diagnosis (CAD) reliability. The method uses White Blood Cell (WBC) segmentation to improve deep learning accuracy and provide visual explanations for diagnoses.

Keywords:
XAIacute lymphoblastic leukemiadeep-learningleukemia classificationnuclei segmentation

More Related Videos

Label-Free Identification of Lymphocyte Subtypes Using Three-Dimensional Quantitative Phase Imaging and Machine Learning
08:58

Label-Free Identification of Lymphocyte Subtypes Using Three-Dimensional Quantitative Phase Imaging and Machine Learning

Published on: November 19, 2018

12.6K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.0K

Related Experiment Videos

Last Updated: Jul 23, 2025

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.5K
Label-Free Identification of Lymphocyte Subtypes Using Three-Dimensional Quantitative Phase Imaging and Machine Learning
08:58

Label-Free Identification of Lymphocyte Subtypes Using Three-Dimensional Quantitative Phase Imaging and Machine Learning

Published on: November 19, 2018

12.6K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.0K

Area of Science:

  • Medical Imaging
  • Artificial Intelligence
  • Oncology

Background:

  • Leukemia poses significant health challenges with high mortality rates.
  • Computer-aided diagnosis (CAD) shows promise but faces reliability issues due to the
  • black box problem
  • in deep learning models.

Purpose of the Study:

  • To develop an Explainable AI (XAI) leukemia classification method.
  • To address the unreliability of deep learning in medical diagnosis.
  • To enhance CAD systems for leukemia with improved interpretability and accuracy.

Main Methods:

  • Integrating White Blood Cell (WBC) nuclei segmentation as a hard attention mechanism.
  • Utilizing a combination of image processing and U-Net techniques for WBC segmentation.
  • Employing modified ResNet-50 models with tested MLP classifiers, activation functions, and training schemes for subtype classification.
  • Incorporating visual explainability and feature space analysis for interpretable classification.

Main Results:

  • Achieved an Intersection over Union (IoU) of 0.91 for the segmentation algorithm across six databases.
  • Attained a 99.9% accuracy for the deep learning classifier in leukemia subtype testing.
  • Confirmed improved network focus on segmented images via Grad CAM and clustering space analysis compared to non-segmented images.

Conclusions:

  • The proposed Explainable AI (XAI) system enhances leukemia classification accuracy and reliability.
  • Visual explainability and feature analysis provide interpretable insights into the diagnostic process.
  • This CAD system has the potential to aid physicians in leukemia diagnosis, ultimately improving patient outcomes.